PortfoliosLab logoPortfoliosLab logo
TMDX vs. HCA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TMDX vs. HCA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TransMedics Group, Inc. (TMDX) and HCA Healthcare, Inc. (HCA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMDX achieves a -40.07% return, which is significantly lower than HCA's -16.94% return.


TMDX

1D
-0.92%
1M
15.36%
YTD
-40.07%
6M
-42.50%
1Y
-48.97%
3Y*
-4.58%
5Y*
20.83%
10Y*

HCA

1D
2.29%
1M
-8.47%
YTD
-16.94%
6M
-19.89%
1Y
5.01%
3Y*
12.30%
5Y*
13.79%
10Y*
18.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMDX vs. HCA - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
TMDX
TransMedics Group, Inc.
-40.07%95.11%-21.01%27.88%222.13%-3.72%4.68%-6.12%
HCA
HCA Healthcare, Inc.
-16.94%56.71%11.75%13.83%-5.64%57.58%12.07%20.25%

Correlation

The correlation between TMDX and HCA is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since May 2, 2019

0.22

The correlation between TMDX and HCA shifts across timeframes, from 0.11 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

TMDX:

$4.34

HCA:

$28.46

PE Ratio

TMDX:

16.80

HCA:

13.60

PEG Ratio

TMDX:

0.04

HCA:

1.62

PS Ratio

TMDX:

4.54

HCA:

1.22

Total Revenue (TTM)

TMDX:

$635.89M

HCA:

$75.60B

Gross Profit (TTM)

TMDX:

$375.74M

HCA:

$31.37B

EBITDA (TTM)

TMDX:

$125.51M

HCA:

$15.60B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMDX vs. HCA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMDX
TMDX Risk / Return Rank: 88
Overall Rank
TMDX Sharpe Ratio Rank: 99
Sharpe Ratio Rank
TMDX Sortino Ratio Rank: 1010
Sortino Ratio Rank
TMDX Omega Ratio Rank: 1111
Omega Ratio Rank
TMDX Calmar Ratio Rank: 1010
Calmar Ratio Rank
TMDX Martin Ratio Rank: 11
Martin Ratio Rank

HCA
HCA Risk / Return Rank: 4646
Overall Rank
HCA Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
HCA Sortino Ratio Rank: 4242
Sortino Ratio Rank
HCA Omega Ratio Rank: 4343
Omega Ratio Rank
HCA Calmar Ratio Rank: 4646
Calmar Ratio Rank
HCA Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMDX vs. HCA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and HCA Healthcare, Inc. (HCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TMDXHCADifference
Sharpe ratioReturn per unit of total volatility

-1.03

Sortino ratioReturn per unit of downside risk

-1.59

Omega ratioGain probability vs. loss probability

0.86

1.06

-0.20

Calmar ratioReturn relative to maximum drawdown

-0.84

0.15

-0.98

Martin ratioReturn relative to average drawdown

-1.99

0.44

-2.43

TMDX vs. HCA - Sharpe Ratio Comparison

The current TMDX Sharpe Ratio is -0.85, which is lower than the HCA Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of TMDX and HCA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TMDX vs. HCA - Drawdown Comparison

The maximum TMDX drawdown since its inception was -73.69%, which is greater than HCA's maximum drawdown of -54.74%. Use the drawdown chart below to compare losses from any high point for TMDX and HCA.


Loading charts...

Drawdown Indicators


TMDXHCADifference

Max Drawdown

Largest peak-to-trough decline

-73.69%

-54.74%

-18.95%

Max Drawdown (1Y)

Largest decline over 1 year

-58.76%

-33.62%

-25.14%

Max Drawdown (3Y)

Largest decline over 3 years

-67.79%

-33.62%

-34.17%

Max Drawdown (5Y)

Largest decline over 5 years

-67.79%

-39.49%

-28.30%

Max Drawdown (10Y)

Largest decline over 10 years

-54.74%

Current Drawdown

Current decline from peak

-58.60%

-28.87%

-29.73%

Average Drawdown

Average peak-to-trough decline

-31.89%

-11.04%

-20.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.65%

11.15%

+13.50%

Volatility

TMDX vs. HCA - Volatility Comparison

TransMedics Group, Inc. (TMDX) has a higher volatility of 12.66% compared to HCA Healthcare, Inc. (HCA) at 8.97%. This indicates that TMDX's price experiences larger fluctuations and is considered to be riskier than HCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TMDXHCADifference

Volatility (1M)

Calculated over the trailing 1-month period

12.66%

8.97%

+3.69%

Volatility (6M)

Calculated over the trailing 6-month period

43.87%

21.53%

+22.34%

Volatility (1Y)

Calculated over the trailing 1-year period

58.06%

27.33%

+30.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.00%

29.90%

+42.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.72%

32.63%

+39.09%

Dividends

TMDX vs. HCA - Dividend Comparison

TMDX has not paid dividends to shareholders, while HCA's dividend yield for the trailing twelve months is around 0.76%.


PositionTTM20252024202320222021202020192018
HCA
HCA Healthcare, Inc.
0.76%0.62%0.88%0.89%0.93%0.75%0.63%1.08%1.12%
TMDX
TransMedics Group, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TMDX vs. HCA - Financials Comparison

This section allows you to compare key financial metrics between TransMedics Group, Inc. and HCA Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
173.93M
19.51B
(TMDX) Total Revenue
(HCA) Total Revenue
Values in USD except per share items

TMDX vs. HCA - Profitability Comparison

The chart below illustrates the profitability comparison between TransMedics Group, Inc. and HCA Healthcare, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
58.2%
41.9%
Portfolio components
TMDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a gross profit of 101.16M and revenue of 173.93M. Therefore, the gross margin over that period was 58.2%.

HCA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a gross profit of 8.18B and revenue of 19.51B. Therefore, the gross margin over that period was 41.9%.

TMDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported an operating income of 13.30M and revenue of 173.93M, resulting in an operating margin of 7.6%.

HCA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported an operating income of 3.18B and revenue of 19.51B, resulting in an operating margin of 16.3%.

TMDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a net income of 7.32M and revenue of 173.93M, resulting in a net margin of 4.2%.

HCA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a net income of 1.88B and revenue of 19.51B, resulting in a net margin of 9.6%.


Frequently Asked Questions


TMDX and HCA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TMDX has higher volatility (12.66%) compared to HCA (8.97%). In terms of maximum drawdown, TMDX dropped -73.69% vs HCA's -54.74%.

HCA currently has the higher Sharpe Ratio (0.18 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TMDX and HCA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer